Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Baum

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Nuklearmedizin. Nuclear Medicine|February 1, 1986
[Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]M Lorenz, J Happ, C Hottenrott, et al.
Nuclear Medicine Communications|August 1, 1995
Validation of a dual-isotope technique using 123I-MIBG and 201Tl in the assessment of sympathetic reinnervation following heart transplantation: phantom and patient studiesB J Krause, C Gürtner, W T Kranert, et al.
HNO|September 1, 1994
[Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure]J Kiefer, R P Baum, R Knecht, et al.
European Journal of Nuclear Medicine|September 2, 1998
Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findingsS Adams, R P Baum, A Hertel, et al.
Cancer|February 1, 1994
Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomasR P Baum, A Niesen, A Hertel, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 14, 2015
The long history of the International Research Group in Immuno-Scintigraphy and Therapy (IRIST)J F Chatal, A C Perkins, R P Baum, et al.
Nuclear Medicine Communications|December 16, 1998
Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigenS Adams, R P Baum, A Hertel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2007
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?P Antunes, M Ginj, H Zhang, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
Current treatment options for neuroendocrine tumorsD Hörsch, P Grabowski, C P Schneider, et al.
Nuclear Medicine Communications|October 1, 1987
CA-19-9 and CEA in the differential diagnosis of isolated liver metastases compared to clinical laboratory testsM Lorenz, C Hottenrott, R P Baum, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Nuklearmedizin. Nuclear Medicine|February 1, 1986
[Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]M Lorenz, J Happ, C Hottenrott, et al.
Nuclear Medicine Communications|August 1, 1995
Validation of a dual-isotope technique using 123I-MIBG and 201Tl in the assessment of sympathetic reinnervation following heart transplantation: phantom and patient studiesB J Krause, C Gürtner, W T Kranert, et al.
HNO|September 1, 1994
[Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure]J Kiefer, R P Baum, R Knecht, et al.
European Journal of Nuclear Medicine|September 2, 1998
Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findingsS Adams, R P Baum, A Hertel, et al.
Cancer|February 1, 1994
Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomasR P Baum, A Niesen, A Hertel, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 14, 2015
The long history of the International Research Group in Immuno-Scintigraphy and Therapy (IRIST)J F Chatal, A C Perkins, R P Baum, et al.
Nuclear Medicine Communications|December 16, 1998
Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigenS Adams, R P Baum, A Hertel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2007
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?P Antunes, M Ginj, H Zhang, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
Current treatment options for neuroendocrine tumorsD Hörsch, P Grabowski, C P Schneider, et al.
Nuclear Medicine Communications|October 1, 1987
CA-19-9 and CEA in the differential diagnosis of isolated liver metastases compared to clinical laboratory testsM Lorenz, C Hottenrott, R P Baum, et al.
Pageof 14